Open Payments

ANTONIO PINERO- PILONA

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism
Where
HUDSON, FL
NPI
1720082068
Received
$94,272 in 455 records, 2019 to 2025 ($68,850 general, $25,422 research)
As principal investigator
$1,971,911 of research payments to others in 96 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment36$1,132
2024General payment43$1,230
2023General payment50$4,542
2022General payment37$10,413
2022Research payment2$12,560
2021General payment23$8,293
2021Research payment1$48
2020General payment68$11,907
2020Research payment3$10,353
2019General payment190$31,330
2019Research payment2$2,459

By company

CompanyRecordsAmountYears
Boehringer Ingelheim Pharmaceuticals, Inc.47$28,3932019–2025
Eli Lilly and Company8$25,4222019–2022
Lilly USA, LLC61$22,4052019–2025
Novo Nordisk Inc54$10,1732019–2025
Amgen Inc.50$1,4462019–2025
SANOFI-AVENTIS U.S. LLC25$8152019–2025
Corcept Therapeutics22$5742022–2025
Amarin Pharma, Inc.11$4772019–2021
Medtronic, Inc.6$4352023–2025
Insulet Corporation16$4112019–2025
AstraZeneca Pharmaceuticals LP22$4002019–2020
Janssen Pharmaceuticals, Inc8$3082019–2020
Bayer Healthcare Pharmaceuticals Inc.13$2912022–2025
Dexcom, Inc.11$2662019–2024
IBSA Pharma Inc.11$2352019–2025
Tandem Diabetes Care, Inc.3$2282020–2025
Radius Health, Inc.6$2282019–2025
Astellas Pharma US Inc4$1682023–2024
Medtronic MiniMed, Inc.3$1662019–2020
Merck Sharp & Dohme LLC12$1532019–2020
Senseonics, Incorporated2$1402019
Xeris Pharmaceuticals, Inc.7$1372022–2023
BETA BIONICS, INC.5$1212024–2025
Abbott Laboratories7$1202019–2025
PFIZER INC.5$762019–2024
Amneal Pharmaceuticals LLC5$702019–2025
Esperion Therapeutics, Inc.1$702024
Ipsen Biopharmaceuticals, Inc3$642019–2021
Antares Pharma, Inc.3$472019–2021
Lexicon Pharmaceuticals, Inc.2$452023–2024
RECORDATI_RARE_DISEASES_INC.2$432022–2024
Novartis Pharmaceuticals Corporation2$352022
Valeritas, Inc.2$342019
Mannkind Corporation2$342019–2020
OPKO Pharmaceuticals, LLC2$332019
Companion Medical, Inc.2$322019–2020
Kowa Pharmaceuticals America, Inc.2$282019–2022
Soleno Therapeutics, Inc.1$202025
Chiesi USA, Inc.1$192025
Sandoz Inc.1$182025
SUN PHARMACEUTICAL INDUSTRIES INC.1$162020
Amryt Pharma Holdings Ltd1$152023
Nevro Corp.1$152024
Alnylam Pharmaceuticals Inc.1$142024
Ferring Pharmaceuticals Inc.1$122019

By nature of payment

NatureRecordsAmount
Compensation for services other than consulting, including serving as faculty or as a speaker at a v35$45,986
Research payment8$25,422
Food and Beverage381$11,038
Travel and Lodging23$8,774
Consulting Fee1$2,925
Education7$125

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-18Amgen Inc.$21Food and BeverageIn-kind items and servicesREPATHA Biological, Cardiovascular2025
2025-11-14Corcept Therapeutics$13Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-10-29Lilly USA, LLC$27Food and BeverageIn-kind items and servicesJARDIANCE Drug, Diabetes2025
2025-10-28Boehringer Ingelheim Pharmaceuticals, Inc.$14Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-10-16Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2025
2025-10-09Bayer Healthcare Pharmaceuticals Inc.$27Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-03Abbott Laboratories$22Food and BeverageIn-kind items and servicesFREESTYLE LIBRE 2 Device, Diabetes Care2025
2025-09-30Medtronic, Inc.$180Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2025
2025-08-14Amgen Inc.$18Food and BeverageIn-kind items and servicesREPATHA Biological, Cardiovascular2025
2025-08-08BETA BIONICS, INC.$19Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2025
2025-08-05Boehringer Ingelheim Pharmaceuticals, Inc.$15Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-07-10Chiesi USA, Inc.$19Food and BeverageCash or cash equivalentMYCAPSSA Drug, ACROMEGALY2025
2025-07-09Soleno Therapeutics, Inc.$20Food and BeverageIn-kind items and servicesVYKAT XR Drug, Prader-Willi syndrome2025
2025-06-19Abbott Laboratories$22Food and BeverageIn-kind items and servicesFREESTYLE LIBRE 2 Device, Diabetes Care2025
2025-06-17Sandoz Inc.$18Food and BeverageIn-kind items and servicesHYRIMOZ Biological, Immunology2025
2025-05-29Tandem Diabetes Care, Inc.$107Food and BeverageIn-kind items and servicest:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2025
2025-05-29Amneal Pharmaceuticals LLC$15Food and BeverageIn-kind items and servicesUNITHROID Drug, ENDOCRINOLOGY2025
2025-05-21Lilly USA, LLC$19Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-05-14BETA BIONICS, INC.$28Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2025
2025-04-23Corcept Therapeutics$24Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-04-17IBSA Pharma Inc.$24Food and BeverageCash or cash equivalentTirosint Drug, Endocrinology2025
2025-04-15SANOFI-AVENTIS U.S. LLC$88Food and BeverageIn-kind items and servicesTZIELD Biological, Endocrine & Metabolic Diseases2025
2025-04-08Amgen Inc.$15Food and BeverageIn-kind items and servicesREPATHA Biological, Cardiovascular2025
2025-04-03Bayer Healthcare Pharmaceuticals Inc.$14Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-03-13Bayer Healthcare Pharmaceuticals Inc.$29Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-03-11Boehringer Ingelheim Pharmaceuticals, Inc.$14Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-02-27Insulet Corporation$20Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-02-24Novo Nordisk Inc$18Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-02-19Radius Health, Inc.$86Food and BeverageIn-kind items and servicesTymlos Drug, Endocrinology2025
2025-02-11Insulet Corporation$22Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-02-06Bayer Healthcare Pharmaceuticals Inc.$25Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-02-05Lilly USA, LLC$17Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-01-23Lilly USA, LLC$17Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-01-22Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-01-16Insulet Corporation$26Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-01-09Corcept Therapeutics$24Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2024-12-20IBSA Pharma Inc.$22Food and BeverageCash or cash equivalentTirosint Drug, Endocrinology2024
2024-12-18Corcept Therapeutics$101Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-12-12Esperion Therapeutics, Inc.$70Food and BeverageIn-kind items and servicesNEXLIZET Drug, ANTILIPEMIC AGENTS2024
2024-12-11Corcept Therapeutics$8Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-12-05Bayer Healthcare Pharmaceuticals Inc.$23Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-11-12Boehringer Ingelheim Pharmaceuticals, Inc.$13Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2024
2024-10-18Corcept Therapeutics$11EducationIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-10-17Bayer Healthcare Pharmaceuticals Inc.$10Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-10-04Bayer Healthcare Pharmaceuticals Inc.$21Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-09-26Medtronic, Inc.$21Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2024
2024-09-18SANOFI-AVENTIS U.S. LLC$97Food and BeverageIn-kind items and servicesTZIELD Biological, Endocrine & Metabolic Diseases2024
2024-09-18BETA BIONICS, INC.$23Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2024
2024-09-12Novo Nordisk Inc$14Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2024
2024-09-11Bayer Healthcare Pharmaceuticals Inc.$25Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-09-10Medtronic, Inc.$13Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2024
2024-09-10Corcept Therapeutics$8Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-08-09Alnylam Pharmaceuticals Inc.$14Food and BeverageIn-kind items and servicesGIVLAARI Drug, Genetic Disease2024
2024-08-07Medtronic, Inc.$109Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2024
2024-06-27Lexicon Pharmaceuticals, Inc.$23Food and BeverageIn-kind items and services2024
2024-06-12BETA BIONICS, INC.$21Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2024
2024-06-11Lilly USA, LLC$13Food and BeverageIn-kind items and servicesJARDIANCE Drug, Diabetes2024
2024-06-05Medtronic, Inc.$18Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2024
2024-05-30RECORDATI_RARE_DISEASES_INC.$22Food and BeverageIn-kind items and servicesSIGNIFOR LAR Drug, ENDOCRINE AGENT2024
2024-05-29Corcept Therapeutics$9Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-05-23Corcept Therapeutics$9Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-05-14Corcept Therapeutics$21Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-05-14PFIZER INC.$17Food and BeverageIn-kind items and servicesSOMAVERT Drug, ENDOCRINE DISEASE;METABOLIC DISEASE2024
2024-05-09Bayer Healthcare Pharmaceuticals Inc.$28Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-05-08BETA BIONICS, INC.$29Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2024
2024-04-25Corcept Therapeutics$25Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-04-12Amgen Inc.$16Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2024
2024-04-05Corcept Therapeutics$24Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2024
2024-03-22IBSA Pharma Inc.$22Food and BeverageCash or cash equivalentTirosint Drug, Endocrinology2024
2024-03-07Novo Nordisk Inc$17Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2024
2024-03-07Amgen Inc.$16Food and BeverageIn-kind items and servicesTEPEZZA Biological, Inflammation/Rare Disease2024
2024-03-05Dexcom, Inc.$76Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2024
2024-02-28Astellas Pharma US Inc$28Food and BeverageIn-kind items and servicesVeozah Drug, Biological2024
2024-02-22SANOFI-AVENTIS U.S. LLC$81Food and BeverageIn-kind items and servicesTZIELD Biological, Endocrine & Metabolic Diseases2024
2024-02-21Abbott Laboratories$18Food and BeverageIn-kind items and servicesFREESTYLE LIBRE 2 Device, Diabetes Care2024
2024-02-13Novo Nordisk Inc$19Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2024
2024-02-08Bayer Healthcare Pharmaceuticals Inc.$23Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2024
2024-01-19Nevro Corp.$15Food and BeverageIn-kind items and servicesSenza Device, Spinal Cord Stimulator2024
2024-01-03Novo Nordisk Inc$17Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2024
2023-12-20Corcept Therapeutics$23Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-12-14Novo Nordisk Inc$22Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2023
2023-11-30Lexicon Pharmaceuticals, Inc.$22Food and BeverageIn-kind items and servicesInpefa Drug, Inhibitor of SGLT2 and SGLT12023
2023-11-14Dexcom, Inc.$13Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2023
2023-10-25Xeris Pharmaceuticals, Inc.$23Food and BeverageIn-kind items and servicesGVOKE HYPOPEN Drug, Diabetes2023
2023-10-18SANOFI-AVENTIS U.S. LLC$123Food and BeverageIn-kind items and services2023
2023-10-03Dexcom, Inc.$14Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2023
2023-09-21Amgen Inc.$21Food and BeverageIn-kind items and servicesRepatha Biological, Cardiology2023
2023-09-20Amgen Inc.$119Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2023
2023-09-19Amgen Inc.$13Food and BeverageIn-kind items and servicesRepatha Biological, Cardiology2023
2023-09-08Corcept Therapeutics$22Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-09-07Bayer Healthcare Pharmaceuticals Inc.$20Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2023
2023-09-05Lilly USA, LLC$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2023
2023-09-01Dexcom, Inc.$23Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2023
2023-08-31Astellas Pharma US Inc$95Food and BeverageIn-kind items and servicesVeozah Drug, Biological2023
2023-08-25Dexcom, Inc.$18Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2023
2023-08-24Corcept Therapeutics$23Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-08-17Bayer Healthcare Pharmaceuticals Inc.$17Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2023
2023-08-16Astellas Pharma US Inc$25Food and BeverageIn-kind items and servicesVeozah Drug, Biological2023
2023-08-04Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2023
2023-08-02Corcept Therapeutics$22Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-07-19Corcept Therapeutics$25Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-07-18IBSA Pharma Inc.$23Food and BeverageCash or cash equivalentLICART Drug, non-opioid analgesic2023
2023-06-29Corcept Therapeutics$18Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-06-16Astellas Pharma US Inc$19Food and BeverageIn-kind items and servicesVeozah Drug, Biological2023
2023-06-07Xeris Pharmaceuticals, Inc.$17Food and BeverageIn-kind items and servicesGVOKE HYPOPEN Drug, Diabetes2023
2023-06-06Xeris Pharmaceuticals, Inc.$19Food and BeverageIn-kind items and servicesGVOKE HYPOPEN Drug, Diabetes2023
2023-05-24SANOFI-AVENTIS U.S. LLC$18Food and BeverageIn-kind items and servicesSOLIQUA 100/33 Biological, Endocrine & Metabolic Diseases2023
2023-05-24Amryt Pharma Holdings Ltd$15Food and BeverageIn-kind items and servicesMYALEPT Drug, Endocrinology2023
2023-05-17Medtronic, Inc.$91Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2023
2023-05-04SANOFI-AVENTIS U.S. LLC$23Food and BeverageIn-kind items and servicesTOUJEO Biological, Endocrine & Metabolic Diseases2023
2023-04-28IBSA Pharma Inc.$24Food and BeverageCash or cash equivalentLICART Drug, non-opioid analgesic2023
2023-04-26Corcept Therapeutics$20Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-04-25Boehringer Ingelheim Pharmaceuticals, Inc.$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2023
2023-04-21Novo Nordisk Inc$22Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2023
2023-04-20Novo Nordisk Inc$20Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2023
2023-04-04Boehringer Ingelheim Pharmaceuticals, Inc.$1,800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2023
2023-03-31SANOFI-AVENTIS U.S. LLC$14Food and BeverageIn-kind items and servicesTOUJEO Biological, Endocrine & Metabolic Diseases2023
2023-03-23Boehringer Ingelheim Pharmaceuticals, Inc.$123Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2023
2023-03-22PFIZER INC.$15Food and BeverageIn-kind items and servicesSOMAVERT Drug, ENDOCRINE DISEASE;METABOLIC DISEASE2023
2023-03-16SANOFI-AVENTIS U.S. LLC$18Food and BeverageIn-kind items and servicesTOUJEO Biological, Endocrine & Metabolic Diseases2023
2023-03-15Corcept Therapeutics$21Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-02-24Corcept Therapeutics$19Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2023
2023-02-17Amgen Inc.$15Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2023
2023-02-16Amgen Inc.$15Food and BeverageIn-kind items and servicesRepatha Biological, Cardiology2023
2023-01-31Boehringer Ingelheim Pharmaceuticals, Inc.$56Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2023
2023-01-25SANOFI-AVENTIS U.S. LLC$21Food and BeverageIn-kind items and servicesSOLIQUA 100/33 Biological, Endocrine & Metabolic Diseases2023
2023-01-21Lilly USA, LLC$21Food and BeverageIn-kind items and servicesJARDIANCE Drug, Diabetes2023
2023-01-19SANOFI-AVENTIS U.S. LLC$23Food and BeverageIn-kind items and servicesTOUJEO Biological, Endocrine & Metabolic Diseases2023
2023-01-18IBSA Pharma Inc.$24Food and BeverageCash or cash equivalentLICART Drug, non-opioid analgesic2023
2022-12-29Lilly USA, LLC$23Food and BeverageIn-kind items and servicesJARDIANCE Drug, Diabetes2022
2022-12-28IBSA Pharma Inc.$23Food and BeverageCash or cash equivalentTirosint Drug, Endocrinology2022
2022-12-13Dexcom, Inc.$20Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2022
2022-11-23Kowa Pharmaceuticals America, Inc.$13Food and BeverageCash or cash equivalentLivalo Drug, Cardiovascular2022
2022-11-11Novartis Pharmaceuticals Corporation$14Food and BeverageIn-kind items and servicesLEQVIO Drug, CARDIOVASCULAR2022
2022-11-09Amgen Inc.$100Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2022
2022-11-09Novo Nordisk Inc$23Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2022
2022-10-27Tandem Diabetes Care, Inc.$85Food and BeverageCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2022
2022-10-20Lilly USA, LLC$18Food and BeverageIn-kind items and servicesBAQSIMI Drug, Diabetes2022
2022-10-14Novartis Pharmaceuticals Corporation$20Food and BeverageIn-kind items and servicesENTRESTO Drug, CARDIOVASCULAR2022
2022-10-13Bayer Healthcare Pharmaceuticals Inc.$24Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-renal2022
2022-10-12Radius Health, Inc.$27Food and BeverageIn-kind items and servicesTymlos Biological, Endocrinology2022
2022-10-10Lilly USA, LLC$18Food and BeverageIn-kind items and servicesJARDIANCE Drug, Diabetes2022
2022-10-06Xeris Pharmaceuticals, Inc.$16Food and BeverageIn-kind items and servicesGVOKE PFS Drug, Diabetes2022
2022-09-29Boehringer Ingelheim Pharmaceuticals, Inc.$1,800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2022
2022-09-22Boehringer Ingelheim Pharmaceuticals, Inc.$381Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-09-22Boehringer Ingelheim Pharmaceuticals, Inc.$121Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-09-21Novo Nordisk Inc$21Food and BeverageIn-kind items and servicesTresiba Drug, Diabetes2022
2022-09-06Dexcom, Inc.$19Food and BeverageIn-kind items and servicesDexcom G6 Transmitter Medical Supply, Endocrinology2022
2022-08-12Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2022
2022-07-28Boehringer Ingelheim Pharmaceuticals, Inc.$2,125Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2022
2022-07-20Boehringer Ingelheim Pharmaceuticals, Inc.$1,245Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-07-20Boehringer Ingelheim Pharmaceuticals, Inc.$55Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-07-17Eli Lilly and Company$11,271Research paymentIn-kind items and servicesA PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 A2022
2022-07-11Novo Nordisk Inc$6Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2022
2022-06-30Novo Nordisk Inc$12Food and BeverageIn-kind items and servicesTresiba Drug, Diabetes2022
2022-06-10Lilly USA, LLC$11EducationIn-kind items and services2022
2022-05-19Xeris Pharmaceuticals, Inc.$19Food and BeverageIn-kind items and servicesGVOKE PFS Drug, Diabetes2022
2022-04-26Corcept Therapeutics$94Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2022
2022-04-12PFIZER INC.$14Food and BeverageIn-kind items and servicesSOMAVERT Drug, ENDOCRINE DISEASE;METABOLIC DISEASE2022
2022-04-08Eli Lilly and Company$1,289Research paymentIn-kind items and servicesA RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2022
2022-04-07Lilly USA, LLC$975Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2022
2022-03-30RECORDATI_RARE_DISEASES_INC.$20Food and BeverageIn-kind items and servicesSIGNIFOR LAR Drug, ENDOCRINE AGENT2022
2022-03-09Boehringer Ingelheim Pharmaceuticals, Inc.$2,125Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2022
2022-03-03Boehringer Ingelheim Pharmaceuticals, Inc.$691Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-03-03Boehringer Ingelheim Pharmaceuticals, Inc.$56Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2022
2022-03-03Xeris Pharmaceuticals, Inc.$18Food and BeverageIn-kind items and servicesGVOKE PFS Drug, Diabetes2022
2022-02-24Novo Nordisk Inc$119Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2022
2022-02-10Xeris Pharmaceuticals, Inc.$22Food and BeverageIn-kind items and servicesGVOKE PFS Drug, Diabetes2022
2021-12-02SANOFI-AVENTIS U.S. LLC$17Food and BeverageIn-kind items and servicesSOLIQUA 100/33 Biological, Endocrine & Metabolic Diseases2021
2021-09-28Lilly USA, LLC$975Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2021
2021-08-10Radius Health, Inc.$28Food and BeverageIn-kind items and servicesTymlos Biological, Endocrinology2021
2021-08-03Boehringer Ingelheim Pharmaceuticals, Inc.$1,950Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2021
2021-08-03Ipsen Biopharmaceuticals, Inc$19Food and BeverageIn-kind items and servicesSOMATULINE DEPOT Drug, Oncology/Endocrinology2021
2021-07-28Amarin Pharma, Inc.$20Food and BeverageIn-kind items and servicesVascepa Drug, Cardiovascular2021
2021-07-16Boehringer Ingelheim Pharmaceuticals, Inc.$1,126Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2021
2021-07-16Boehringer Ingelheim Pharmaceuticals, Inc.$89Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2021
2021-07-13Amarin Pharma, Inc.$22Food and BeverageIn-kind items and servicesVascepa Drug, Cardiovascular2021
2021-06-08Amarin Pharma, Inc.$23Food and BeverageIn-kind items and servicesVascepa Drug, Cardiovascular2021
2021-05-18Radius Health, Inc.$22Food and BeverageIn-kind items and servicesTymlos Biological, Endocrinology2021
2021-05-13Novo Nordisk Inc$18Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2021
2021-05-11Boehringer Ingelheim Pharmaceuticals, Inc.$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2021
2021-05-01Antares Pharma, Inc.$13Food and BeverageIn-kind items and servicesXYOSTED Drug, Testosterone Replacement Therapy2021
2021-04-13Boehringer Ingelheim Pharmaceuticals, Inc.$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2021
2021-04-13Amgen Inc.$11Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2021
2021-03-18Boehringer Ingelheim Pharmaceuticals, Inc.$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2021
2021-03-17Lilly USA, LLC$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2021
2021-03-12SANOFI-AVENTIS U.S. LLC$16Food and BeverageIn-kind items and servicesSOLIQUA 100/33 Biological, Endocrine & Metabolic Diseases2021
2021-03-09Lilly USA, LLC$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2021
2021-03-05SANOFI-AVENTIS U.S. LLC$16Food and BeverageIn-kind items and servicesTOUJEO Biological, Endocrine & Metabolic Diseases2021
2021-02-25Novo Nordisk Inc$22Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2021
2021-02-16Lilly USA, LLC$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2021
2021-01-29Eli Lilly and Company$48Research paymentIn-kind items and servicesA RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2021
2020-12-16Amgen Inc.$0EducationIn-kind items and services2020
2020-12-02Amgen Inc.$0EducationIn-kind items and services2020
2020-10-08Eli Lilly and Company$1,092Research paymentIn-kind items and servicesA RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2020
2020-09-22Lilly USA, LLC$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2020
2020-09-03Novo Nordisk Inc$4Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2020
2020-08-28Novo Nordisk Inc$15Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2020
2020-08-28Novo Nordisk Inc$11Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2020
2020-07-28Boehringer Ingelheim Pharmaceuticals, Inc.$650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2020

The latest 200 records of 455.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-31ABBVIE INC.ATLAS INTERMEDIATE$5,587A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and sa2025
2025-12-05ABBVIE INC.ATLAS INTERMEDIATE LLC$13,789A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-11-05ABBVIE INC.ATLAS INTERMEDIATE LLC$12,509A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-10-24Amgen Inc.ATLAS INTERMEDIATE LLC SUNCOAST CLINICAL RESEARCH LLC$21,662A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiov2025
2025-10-21ABBVIE INC.ATLAS INTERMEDIATE LLC$405A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-10-09ABBVIE INC.ATLAS INTERMEDIATE LLC$7,935A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-09-24Amgen Inc.SUNCOAST CLINICAL RESEARCH INC$1,653A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiov2025
2025-09-04ABBVIE INC.ATLAS INTERMEDIATE LLC$14,535A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-08-06ABBVIE INC.ATLAS INTERMEDIATE LLC$6,588A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-07-02ABBVIE INC.ATLAS INTERMEDIATE LLC$3,922A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-06-03ABBVIE INC.ATLAS INTERMEDIATE LLC$15,556A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-05-20ABBVIE INC.ATLAS INTERMEDIATE LLC$202A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-05-20ABBVIE INC.ATLAS INTERMEDIATE LLC$1,113A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-05-07ABBVIE INC.ATLAS INTERMEDIATE LLC$2,775A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-04-24ABBVIE INC.ATLAS INTERMEDIATE LLC$4,500A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-04-24ABBVIE INC.ATLAS INTERMEDIATE LLC$600A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-04-16ABBVIE INC.ATLAS INTERMEDIATE LLC$600A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-04-09ABBVIE INC.ATLAS INTERMEDIATE LLC$600A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-04-03ABBVIE INC.ATLAS INTERMEDIATE LLC$9,776A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2025
2025-03-18ABBVIE INC.ATLAS INTERMEDIATE LLC$4,943M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of2025
2025-02-06ABBVIE INC.ATLAS INTERMEDIATE LLC$2,546M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of2025
2024-12-31ABBVIE INC.SUNCOAST CLINICAL RESEARCH INC$4,624M21-341 ATH Ph 2b Armour Thyroid vs Synthetic T4 (ATH-MD-01) (3014-301-002)2024
2024-12-30ABBVIE INC.ATLAS INTERMEDIATE LLC$11,962A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-12-05ABBVIE INC.ATLAS INTERMEDIATE LLC$4,873A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-11-07ABBVIE INC.ATLAS INTERMEDIATE LLC$5,719A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Sa2024
2024-10-03ABBVIE INC.ATLAS INTERMEDIATE LLC$16,411A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-09-04ABBVIE INC.ATLAS INTERMEDIATE LLC$23,889A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-08-02ABBVIE INC.ATLAS INTERMEDIATE LLC$9,140A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-06-06ABBVIE INC.ATLAS INTERMEDIATE LLC$16,000A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H2024
2024-01-09Eli Lilly and CompanyMARIN ENDOCRINE CARE AND RESEARCH$338A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 A2024
2024-01-02Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$15,723A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 A2024
2023-05-08Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$244,931A PHASE 3 MULTICENTER RANDOMIZED PARALLEL-DESIGN OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 AS A 2023
2023-04-10Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$11,357A PHASE 3 MULTICENTER RANDOMIZED PARALLEL-DESIGN OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 AS A 2023
2023-02-06Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$2,200A RANDOMIZED PHASE 3 OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN LIS2023
2023-01-23Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$3,000A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2023
2023-01-10Eli Lilly and CompanyMARIN ENDOCRINE CARE AND RESEARCH$8,786A PHASE 3 MULTICENTER RANDOMIZED PARALLEL-DESIGN OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 AS A 2023
2022-08-05Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$8,412A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 A2022
2022-06-22Eli Lilly and CompanyMARIN ENDOCRINE CARE AND RESEARCH$1,854A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 A2022
2022-03-28Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$6,750A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902022
2022-03-28Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$5,200A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2022
2022-01-31Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$1,040A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902022
2022-01-26Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$116A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2022
2022-01-25Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$32,048A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2022
2022-01-11Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$297A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2022
2021-11-26Welch AllynSUNCOAST CLINICAL RESEARCH$19,508AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-11-26Welch AllynSUNCOAST CLINICAL RESEARCH$550AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-10-08Welch AllynSUNCOAST CLINICAL RESEARCH$3,850AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-10-01Welch AllynSUNCOAST CLINICAL RESEARCH$39,937AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-10-01Welch AllynSUNCOAST CLINICAL RESEARCH$39,937AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-05-31Eli Lilly and CompanySan Miguel Medical$48A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-05-10Eli Lilly and CompanyMILLENNIUM RESEARCH LLC$132A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-05-10Eli Lilly and CompanyANDROSCOGGIN CARDIO ASSOC DBA MAINE RSRH ASSOC$202A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-05-10Eli Lilly and CompanyNEW HORIZON RESEARCH CENTER$38A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-05-10Eli Lilly and CompanyUNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL$22A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-04-30Eli Lilly and CompanyEmanuelli Research and Development Center, LLC$48A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-04-13Eli Lilly and CompanyDALLAS DIABETES AND ENDO RESEARCH CENTER PA$3,112A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-04-08Eli Lilly and CompanyGCM MEDICAL GROUP PSC$47A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-04-08Eli Lilly and CompanyCLINICAL RESEARCH ADVANTAGE$15A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-03-12Welch AllynSUNCOAST CLINICAL RESEARCH$5,595AutoDx-DR Prospective Clinical Validation Study Protocol2021
2021-03-09Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$84,651A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2021
2021-02-23Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$1,088A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2021
2021-01-12Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$8,215A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2021
2021-01-11Eli Lilly and CompanyDANA-FARBER CANCER INSTITUTE$464A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2021
2021-01-11Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$10,264A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-01-11Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$17,544A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-01-05Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$173,242A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-01-05Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$163,801A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2020-12-22Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$23,132A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902020
2020-10-12Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$777A STUDY OF LY900014 IN PARTICIPANTS WITH TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING2020
2020-09-22Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$2,356A RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2020
2020-07-23Eli Lilly and CompanySUNCOAST RESEARCH$217A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902020
2020-03-27Eli Lilly and CompanyINTEND RESEARCH LLC$86A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2020
2020-03-04Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$12,863A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902020
2020-01-28Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$292A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2020
2020-01-28Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$136A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG IN ADULTS WITH TYPE 1 DIABETES USING CONTINUOU2020
2020-01-21Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$16,825A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG IN ADULTS WITH TYPE 1 DIABETES USING CONTINUOU2020
2020-01-21Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$144,143A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2020
2020-01-13Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$12,635A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2020
2020-01-09Eli Lilly and CompanyDana-Farber Cancer Institute$3,362A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2020
2020-01-08Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$6,094A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2020
2019-09-17SANOFI US SERVICES INC.SUNCOAST CLINICAL RESEARCH INC$1,060A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of2019
2019-09-10Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$26,338A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2019
2019-09-03SANOFI US SERVICES INC.SUNCOAST CLINICAL RESEARCH INC$2,473A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of2019
2019-08-06Eli Lilly and CompanyDana-Farber Cancer Institute$2,041A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2019
2019-08-02Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$5,131A RANDOMIZED, PHASE 3, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS2019
2019-07-16Eli Lilly and CompanyDana-Farber Cancer Institute$11,581A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2019
2019-07-10Eli Lilly and CompanyDana-Farber Cancer Institute$3,141A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG IN ADULTS WITH TYPE 1 DIABETES USING CONTINUOU2019
2019-04-16Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$190,379A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG IN ADULTS WITH TYPE 1 DIABETES USING CONTINUOU2019
2019-02-19Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$4,000A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO INSULIN LISPRO, BOTH IN COMBINATION WITH INSULIN GLARG2019
2019-02-12Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$6,807A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO INSULIN LISPRO WITH AN OPEN-LABEL POSTPRANDIAL LY900012019
2019-02-05Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$258,804A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2019
2019-02-04SANOFI US SERVICES INC.SUNCOAST CLINICAL RESEARCH INC$6,686A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of2019
2019-01-28Eli Lilly and CompanyKENTUCKY DIABETES ENDOCRINOLOGY CENTER$267A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO INSULIN LISPRO WITH AN OPEN-LABEL POSTPRANDIAL LY900012019
2019-01-28Eli Lilly and CompanyMARIN ENDOCRINE CARE AND RESEARCH$3,834A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2019
2019-01-22Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$39,697A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG IN ADULTS WITH TYPE 1 DIABETES USING CONTINUOU2019
2019-01-16Eli Lilly and CompanySUNCOAST CLINICAL RESEARCH$47,952A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Pasco CountyHudson CDP

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Hudson, FL, county Pasco County, FL, state Florida; placed by its city name.

MeasurePlace (city or town)
Hudson, FL
County
Pasco County, FL
State
Florida
Population B0100311,254611,44422,416,077
Population, 2020 census P112,944561,89121,538,187
Median age B0100263.843.442.6
Under 18 B010018.9%20.2%19.5%
65 and over B0100146.4%21.9%21.3%
Households B110015,571236,1638,752,810
Foreign born B050028.6%12.3%21.9%
Median household income B19013$51,513$70,492$74,568
Median family income B19113$73,393$89,308$89,891
Per capita income B19301$36,304$38,864$42,609
Poverty rate B1700113.0%11.1%12.6%
Unemployment rate B230254.6%4.9%4.8%
Civilian labor force B230253,754289,11811,016,578
Mean commute (minutes) B0801334.731.128.0
Bachelor's degree or higher B1500318.0%29.2%34.1%
Housing units B250017,602271,84410,256,470
Owner-occupied B2500377.1%75.7%67.6%
Renters B2500322.9%24.3%32.4%
Median home value B25077$269,200$300,900$359,000
Median gross rent B25064$1,044$1,505$1,669
White, not Hispanic B0300285.6%67.5%50.4%
Black B030021.6%6.0%14.6%
Hispanic or Latino B030027.2%18.6%27.4%
Asian B030021.2%3.4%2.9%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 4.4% in Sep 2026 (4.2% a year earlier); per capita personal income $78,345 in 2025, up 38% in five years (+11.3% after inflation); Unemployment rate: 4.9% in Sep 2016 to 4.4% in Sep 2026; low 2.8%, high 14.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Hudson, FL.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.